Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Geriatric Medicine
•
Functional Assessment and Rehabilitation
•
Dementia
•
General Geriatric Medicine
What were your top take-aways from GSA 2025 in Boston?
Related Questions
Would you recommend a GLP-1 agonist as an option to reduce the risk of dementia in patients with a strong family history?
What is your antipsychotic of choice and general titration regimen in the outpatient setting for a patient with dementia and behavioral disturbances (assuming reversible causes such as urinary retention, constipation, etc. have been addressed)?
Should we be recommending a specific daily protein intake to prevent sarcopenia in geriatric patients, or do you find it more beneficial to focus on encouraging activity within their mobility limitations to preserve muscle mass?
What is the role of antibiotic suppression for the prevention of frequent UTIs in older adult patients?
Do you recommend starting a statin in patients above 75 years old with diabetes but no known ASCVD?
How would you approach the management of asymptomatic ALT and GGT elevation in an older adult patient with depression with psychosis and without history of hepatitis who recently had dose of quetiapine increased and new initiation of SNRI?
When is it useful to test for multiple amyloid-related biomarkers for patients underoing work-up for cognitive impairment?
What is your approach to the use of GLP-1 agonists in older adults with diabetes with or at risk of sarcopenia?
What is your approach to determining eligibility for hospice in persons with Alzheimer's disease?
What is your approach to deprescribing cholinesterase inhibitors and/or memantine in advancing stages of dementia?
